Omega Therapeutics Inc
General ticker "OMGA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $49.3M
Omega Therapeutics Inc does not follow the US Stock Market performance with the rate: -38.0%.
Estimated limits based on current volatility of 5.4%: low 0.78$, high 0.87$
Factors to consider:
- Current price 37.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.30$, 4.00$]
- 2024-12-30 to 2025-12-30 estimated range: [1.33$, 3.82$]
Financial Metrics affecting the OMGA estimates:
- Negative: Non-GAAP EPS, $ of -1.81 <= 0.10
- Negative: Operating profit margin, % of -97.01 <= 1.03
- Negative: Operating cash flow per share per price, % of -42.14 <= 2.35
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: negative Net income
Short-term OMGA quotes
Long-term OMGA plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.14MM | $2.07MM | $3.09MM |
Operating Expenses | $66.18MM | $104.84MM | $103.36MM |
Operating Income | $-66.03MM | $-102.77MM | $-100.26MM |
Non-Operating Income | $-2.25MM | $0.07MM | $2.83MM |
Interest Expense | $0.91MM | $0.22MM | $0.00MM |
R&D Expense | $47.87MM | $80.00MM | $77.17MM |
Income(Loss) | $-68.28MM | $-102.70MM | $-97.43MM |
Profit(Loss) | $-68.28MM | $-102.70MM | $-97.43MM |
Stockholders Equity | $200.63MM | $105.97MM | $58.02MM |
Inventory | $0.26MM | $41.15MM | $0.30MM |
Assets | $233.33MM | $146.00MM | $204.37MM |
Operating Cash Flow | $-57.61MM | $-98.52MM | $-91.51MM |
Capital expenditure | $1.47MM | $1.38MM | $2.87MM |
Investing Cash Flow | $-40.40MM | $-18.06MM | $47.52MM |
Financing Cash Flow | $261.54MM | $0.71MM | $41.82MM |
Earnings Per Share* | $-1.45 | $-2.14 | $-1.80 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.